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Abstract 
Background: The process for obtaining monoclonal antibodies against a specific antigen is very laborious, involves 
sophisticated technologies and it is not available in most research laboratories. Considering that most cytokines 
remain partially conserved among species during evolution, the search for antibody cross‑reactivity is an important 
strategy for immunological studies in veterinary medicine. In this context, the amino acid sequence from human and 
canine cytokines have demonstrated 49–96 % homology, suggesting high probability of cross‑reactivity amongst 
monoclonal antibodies. For this, 17 commercially available anti‑human monoclonal antibodies [IL‑1α, IL‑1β, IL‑2, IL‑4, 
IL‑5, IL‑6, IL‑8 (#1, #2), IL‑10, IL‑12, IL‑13, IL‑17A, IFN‑γ (#1, #2), TNF‑α (#1, #2) and TGF‑β], were evaluated in vitro for intra‑
cellular cytokine detection in a stimulated canine blood culture by flow cytometry and confocal microscopy. Lympho‑
cytes from peripheral blood of healthy and two unhealthy dogs were analyzed.
Results: Eleven anti‑human mAbs [IL‑1α, IL‑4, IL‑5, IL‑6, IL‑8 (#1, #2), IL‑12, IL‑17A, TNF‑α (#1, #2) and TGF‑β] cross‑
reacted against canine intracellular cytokines. The specificity of the assays was not affected after Fc‑blocking. Three 
anti‑human cytokine mAbs [IL‑4, IL‑8 (#2) and TGF‑β] when evaluated by confocal microscopy also cross‑reacted with 
intracellular canine cytokines. The identification of human mAbs that cross‑reacted with canine cytokines may sup‑
port their use as immunological biomarkers in veterinary medicine studies.
Conclusion: The identification of these 11 anti‑human cytokine mAbs that cross‑reacted with canine cytokines will 
be useful immunological biomarkers for pathological conditions by flow cytometry and fluorescence microscopy in 
dogs.
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Background
Cytokines are soluble proteins secreted by different 
cell subtypes including antigen-presenting cells (APC), 
endothelial and epithelial cells, bone marrow stromal 
cells, fibroblasts, keratinocytes, platelets and both lym-
phoid and non-lymphoid cells. They are involved in a wide 
range of interactions such as the development of cellular 
and humoral immune responses, induction of inflamma-
tory responses, regulation of hematopoiesis, control of 
proliferation/differentiation and cell migration [1]. Some 
cytokines [such as interleukin (IL) 6] circulate in picomo-
lar concentrations and may increase by 1000 times dur-
ing infection or trauma [2]. The synthesis of appropriate 
amounts of tumor necrosis factor (TNF-α), IL-1 and IL-6 
is clearly beneficial in response to infection, but higher 
levels may be relevant for immunopathological processes 
[3–6]. Cytokine detection during the immune response 
can be useful prognostic markers in several diseases and 
also provide assessment of vaccine efficacy [7–9].
Animal models are widely used in biological research. 
Dogs, for example, are excellent models for studies of 
immunosuppression and are frequently used for trans-
plants and they are also important as reservoir of visceral 
leishmaniasis. However, differently from humans and 
mice, dog studies are hindered due to a more restricted 
repertoire of commercially available monoclonal anti-
bodies (mAb) against cytokines [10]. Quantification of 
cytokines could be a useful tool for diagnosis and under-
standing inflammatory conditions of domestic animals 
[11]. Thus, there is great demand for reactive antibodies 
against canine molecules, especially anti-cytokines.
As the process for development of monoclonal antibodies 
is laborious, costly, requires sophisticated technologies and 
is not available in most research laboratories, studies regard-
ing cross-reactivity of antibodies against different species of 
cytokines are needed. Several studies have been conducted 
to identify the existence of cross-reactivity of surface mol-
ecules mAbs in animals [10, 12–15]. In 1993, the First Inter-
national Canine Leukocyte Antigen Workshop—CLAW 
was conducted with the aim of identifying antigens of canine 
leukocytes and monoclonal antibodies. Those recognized 
homologous antigens were classified by analogy according to 
the nomenclature “cluster of differentiation” (CD) in human 
and murine [16]. Since then, cross-reactions between mole-
cules expressed by human and animal lymphocytes have been 
reported [17–20]. This phenomenon is expected when the 
amino acid sequence homology among cytokines from differ-
ent species is at least 60 % [21]. Comparative studies of reac-
tivity of mAbs with cells from different species have shown 
that each antibody can recognize different epitopes [12]. 
Kwong et al. [22] produced and tested two bovine monoclo-
nal antibodies against ovine TNF-α and found one with satis-
factory reactivity. Schuberth et al. [18] tested cross-reactivity 
of 164 mAbs for pigs against canine leukocytes, and obtained 
11 % of reactivity. Those data indicated that the recognition 
of conserved epitopes in evolutionarily distant species such as 
dogs and pigs was very low. Pedersen et al. [23] showed the 
existence of cross-reactivity of mAbs against sheep, cattle and 
human cytokines to different species and found cross-reac-
tivity for four antibodies (IL-4, IL-8, IFN-γ and TNF-α) and 
Dorneles et  al. [20] demonstrated that anti-human IL-1-α, 
IL-6, IL-8, IL-17A and IL-10 mAbs cross-react with cattle, 
goat and sheep cytokines. Overall, data on cross-reactivity 
among mAbs against human cytokines and domestic animals 
are scarce, mainly when dog cytokines are concerned. There-
fore, the aim of this study was to screen a panel of 17 mAbs 
against human cytokines for cross-reactivity against canine 
cytokines. Furthermore, we have also performed additional 
analyzes to test the applicability of these antibodies during 
immunopathological disorders in dogs.
Methods
Monoclonal antibodies (mAbs)
Seventeen commercially available human mAbs against 
cytokines were used. All were conjugated with phy-
coerythrin fluorochrome (PE). Information on manu-
facturer, target species, host and catalog numbers are 
provided in the Table  1. Two mAbs against bovine 
cytokines (Serotec, Kidlington, UK) known to recognize 
canine cytokines were used as controls (Table 1). Isotypic 
controls were also included as provided in Table 1.
Animals and controls
Forty-seven Mongrel dogs (Canis lupus familiaris) 
included in this study were selected in veterinary clinics in 
Belo Horizonte, Minas Gerais, Brazil (45 healthy dogs) and 
at the Hospital Veterinário—Escola de Veterinária—Uni-
versidade Federal de Minas Gerais HV—EV—UFMG (two 
diseased dogs). In this cross-reactivity study, cells collected 
from minimum 8 until 45 healthy dogs were evaluated. Fur-
ther, one dog with peritonitis and another with dermatitis 
were included to evaluate the applicability of a selected 
set of anti-cytokine mAbs to characterize the immuno-
logical status under pathological disorders. Blood samples 
from four human volunteers were used as controls. Five ml 
of canine and human peripheral blood were collected in 
heparinized tubes. This study was approved by the Ethical 
Committee for the use of Experimental Animals (CEUA—
P-71/11-3) from the Oswaldo Cruz Foundation, Brazil.
In vitro culture
Short-term whole blood culture was performed accord-
ing to Teixeira-Carvalho et  al. [24] with modifications. 
Briefly, 1  ml of blood samples were cultured in 1  ml of 
RPMI (Invitrogen, Carlsbad, CA, USA) (37  °C, 5  % 
CO2, 4  h). Culture controls were incubated only in the 
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presence of leukocytes plus RPMI. Stimulated cultures 
were incubated in the presence of leukocytes plus phor-
bol 12-myristate 13-acetate (PMA, 25  ng/ml, Sigma, St. 
Louis, MO, USA), ionomycin (ION, 1  μg/mL, Sigma, 
St Louis, MO, USA), and 1 μg/ml of lipopolysaccharide 
(LPS, Sigma, St Louis, MO, USA) (PMA + IONO + LPS). 
Also, Brefeldin A (BFA, 10 μg/ml, Sigma, St Louis, MO, 
USA) was added for all blood cultures to block cytokine 
transport. Following incubation, the cultures were 
treated with 2  mM ethylenediamine tetra acetic acid 
(EDTA) (Sigma, St Louis, MO, USA) and maintained at 
room temperature for 15 min.
Intracellular cytokine immunostaining
Flow cytometric immunophenotyping of intracellular 
cytokines
Following the short-term in  vitro stimulation, eryth-
rocytes were lysed using 6  ml of FACS Lysing Solution 
(Becton–Dickinson, San Jose, CA, USA) under vortex-
ing. After 5 min, the suspension was centrifuged (600×g, 
7 min, room temperature). Then, the samples were incu-
bated with FACS Permeabilizing Solution (0.015 M phos-
phate buffered saline—PBS, supplemented with 0.5  % 
bovine serum albumin, 0.5 % of saponin (Sigma, St Louis, 
MO, USA), and 0.1 % sodium azide, Becton–Dickinson) 
for 7 min. The suspension was centrifuged again (600×g, 
7 min, room temperature). Then, cells were resuspended 
in 1 ml of FACS Permeabilizing Solution. During stand-
ardization procedure, 50 μl of suspension were incubated 
with several dilutions of PE-labeled anti-human cytokine 
mAbs (1:10, 1:25, 1:50 and 1:100), yielding a final con-
centration 0.1–1 μg/ml. According to the titration curve, 
the final concentration of 0.5  μg/ml for all tested anti-
bodies (1:50 dilution of commercial available mAbs). 
The cells were incubated in the dark for 30 min at room 
temperature. After intracytoplasmic cytokine staining, 
cells were washed once (400×g, 10 min, 4 °C) with FACS 
buffer, fixed with 200 μl of FACS FIX Solution (10 g/l of 
paraformaldehyde, 10.2  g/l sodium cacodilate, 6.63  g/l 
sodium chloride, pH 7.2), and stored at 4 °C prior to flow 
cytometry acquisition and analysis. In all experiments, 
internal controls including unstained cells along with 
isotypic matching mAbs and reference cross-reactivity 
reagents (anti-bovine mAbs—IFN-g and IL-4 from Sero-
tec, Kidlington, UK) were added in order to validate the 
cross-reactivity patterns.
The evaluation of cross-reactivity was conducted 
in three steps. First, the reactivity pattern of human 
mAbs was addressed by comparing the labeling profile 
of canine lymphocytes with that observed with human 
Table 1 Monoclonal antibodies tested
Antibody Target Host Isotype Clone Manufacturer Catalog Reactivity
Anti‑IL‑1α Human Mouse IgG1 3643B314 BD 554561 +
Anti‑IL‑1β Human Mouse IgG1 AS10 BD 340516 –
Anti‑IL‑2 Human Mouse IgG1 5344.111 BD 340450 –
Anti‑IL‑4 Human Mouse IgG1 8F‑12 IQProducts IQP162R +
Anti‑IL‑5 Human Rat IgG2 JES139D10 BD 559332 +
Anti‑IL‑6 Human Rat IgG1 MQ2‑13A5 BD 554545 +
Anti‑IL‑8 (#1) Human Mouse IgG2 G265‑8 BD 554720 +
Anti‑IL‑8 (#2) Human Mouse IgG1 E8N1 Biolegend 511408 +
Anti‑IL‑10 Human Rat IgG1 JES3‑16E3 BD 554467 –
Anti‑IL‑12 Human Mouse IgG1 C11.5 BD 554575 +
Anti‑IL‑13 Human Rat IgG1 JES10‑5A2 BD 559328 –
Anti‑IL‑17A Human Mouse IgG1 eBio64DEC17b eBioscience 12‑7179‑73 +
Anti‑IFN‑γ(#1) Human Mouse IgG1 B27 BD 559327 –
Anti‑IFN‑γ(#2) Human Mouse IgG1 45‑15 IQProducts IQP160r –
Anti‑TNF‑α(#1) Human Mouse IgG1 B‑C7 IQProducts IQP163R +
Anti‑TNF‑α(#2) Human Mouse IgG1 mab11 BD 559321 +
Anti‑TGF‑β Human Mouse IgG1 TB21 IQProducts IQP169R +
Isotype control – Mouse IgG1 – BD 555748 –
Isotype control – Mouse IgG2 – BD 556437 –
Isotype control – Rat IgG1 – BD 554685 –
Isotype control – Rat IgG2 – BD 557229 –
Anti‑IL‑4 Bovine Mouse IgG2a CC303 Serotec mca1820pe +
Anti‑IFN‑γ Bovine Mouse IgG1 CC302 Serotec mca1783pe +
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lymphocytes. Second, the cross-reactivity was confirmed 
by using internal controls (isotypic, blocking and refer-
ence cross-reactive mAbs). Blocking was carried out by 
parallel incubation of cells with 2 % of host serum (mouse 
or rat) during the incubation with anti-human cytokine 
mAbs. Third, the cross-reactivity pattern was further val-
idated by comparing the frequency of cytokine positive 
cells observed in healthy and unhealthy dogs.
Flow cytometry acquisition and analysis
Flow cytometry acquisition and analysis were performed 
in a FACScalibur™ flow cytometer (Becton–Dickinson), 
interfaced to an Apple G3 FACStation using the Cell 
Quest software (Franklin Lakes, NJ, USA). After acquir-
ing 20,000 events/tube, the data were used to analyze the 
different cytokine-expressing lymphocytes. The FlowJo 
7.6.1 (Tree Star, Ashland, OR, USA) software was used 
for data analysis. Figure  1 summarizes the data analysis 
used to quantify the frequency of lymphocytes express-
ing intracytoplasmic cytokines. The lymphocyte and 
monocytes gating was based on their size (forward scat-
ter—FSC) and granularity (side scatter—SSC). Those are 
morphometric features on dot plot distributions, where 
they are confined into a region of low size and complexity 
Fig. 1 Gating strategy to quantify cytokine+ canine lymphocytes following short‑term whole blood cultures in vitro. Upper panels (controls) and 
lower panels (stimulated with PMA + LPS). a A plot of spot size distribution (FSC) versus granularity (SSC) used for the selection of the lymphocyte 
population of interest—with the (R1) phenotype FSC × SSC. b Dot plot distribution of cytokine+ cells built by bi‑dimensional graphs of empty 
channel (FL4 fluorescence) versus PE‑emission channel (FL2) were used to quantify the percentage of cytokine+ lymphocytes within R1. The left 
part of the graph (Quadrants Q1 and Q4, highlighted by gray background) was used to compose the figures for subsequent analyses. c In the Q1 
quadrant are shown the percentage (%) of cytokine+ lymphocytes using TNF‑α as example
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(R1) (Fig.  1a). Cytokine-expressing lymphocytes were 
quantified using Fluorescence FL4 versus Fluorescence 
FL2/anti-cytokine-PE dot plots. Then, the FL2 positive 
quadrant (Q1) was selected to show the cytokine produc-
tion (Fig. 1b). When considering antibodies giving weak 
staining signals, the most likely explanation is that the 
fluorescent signals in some cases simply were too weak 
to fall within our criteria of being regarded as positive 
(more than 0.5 % of the lymphocytes positive from stim-
ulated culture). The results were expressed as percent-
age of lymphocytes that express the cytokine of interest 
(Fig. 1c). This pattern (Fig. 1c) was used subsequently in 
all experiments (Figs. 2, 3, 4, 5).
Confocal analysis of intracellular cytokines
After the short-term whole culture, 200 μl of cell suspen-
sion were used for immunostaining for confocal micros-
copy. In 5  ml polypropylene tubes (Becton–Dickinson), 
cell suspension was incubated with 5 μl anti-human CD3 
fluorescein isothiocyanate (FITC) labeled mAb (Serotec, 
Kidlington, UK) for 30  min at room temperature in the 
dark. Then, the erythrocytes were lysed by adding 4  ml 
of FACS Lysing Solution (Becton–Dickinson) under vor-
tex mixing. After 5  min, cells were washed by centrifu-
gation (600×g, 7 min, room temperature). Then, samples 
were incubated with FACS Permeabilizing Solution 
(0.015 M phosphate buffered saline—PBS, supplemented 
with 0.5 % bovine serum albumin, 0.5 % of saponin, and 
0.1  % sodium azide—Becton–Dickinson, San Jose, CA, 
USA) for 5  min and washed by centrifugation (600×g, 
7  min, room temperature). Following, the cells were 
resuspended in 200  μl of FACS Permeabilizing Solu-
tion and 50  μl of the suspension were immunostained 
by adding 1 μl with PE-labeled anti-cytokine mAbs [IL-
4, IL-8(#2) and TGF-β]. Cells were incubated in the dark 
for 30  min at room temperature. Then, the cells were 
washed twice with 2 ml of FACS buffer, resuspended and 
fixed with 50 μl of FACS FIX Solution (BD Pharmigen). 
This cell suspension was placed in the CytoSpin appa-
ratus (Cytospin II, Shandon) and centrifuged (500×g, 
10 min). The samples were mounted and covered by glass 
slides using the antifade agent mowiol (Polysciences, 
Fig. 2 Cross‑reactivity of a range of anti‑human cytokine mAbs with canine cytokines following short‑term whole blood cultures in vitro. Dot plot 
distribution graphs of empty channel (FL4 fluorescence) versus PE‑emission channel (FL2) were used to quantify the percentage of cytokine+ lym‑
phocytes in unstimulated controls (left panels) and PMA + LPS stimulated cultures (right panels). Only Q1 and Q4 quadrants are represented. Gray 
background highlights the reactivity above 0.5 % in the quadrant Q1
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Inc., Warrington, PA, USA). The material was visualized 
using a Zeiss laser scanning inverted microscope (Axio-
vert LSM510) (Carl Zeiss MicroImaging, Inc., Thorn-
wood, NY, USA). The Zeiss LSM Image Browser (Version 
4.2.0.121) software was used for image analysis.
Results
Anti‑human cytokine mAbs cross‑reactivity against canine 
cytokines
The analysis of the frequencies of lymphocytes expressing 
intracytoplasmic cytokines were determined by the strat-
egy of conventional analysis as described using TNF-α 
as an example (Fig.  1). After stimulation, an increase 
(7.25 %) in the percentage of cells expressing the cytokine 
was observed as compared with control culture (1.25 %) 
(Fig. 1, lower right). Following this pattern, all subsequent 
data were obtained for the other cytokines and percent-
ages above 0.5 % were considered reactive, highlighted by 
gray panels in all flow cytometric representative figures. 
Using a panel of seventeen anti-cytokine mAbs it was 
possible to detect cross-reactivity between anti-human 
cytokine mAbs with canine intracytoplasmic cytokines 
for eleven cytokines [IL-1α, IL-4, IL-5, IL-6, IL-8 (#1 
and #2), IL-12, IL-17A, TNF-α (#1 and #2) and TGF-β]. 
As expected, higher production of some cytokines such 
as IL-8, IL-12, IL-17A and TNF-α was observed in the 
PMA + LPS stimulated cultures as compared with con-
trol cultures. On the other hand, anti-IFN-γ mAbs (#1 
and #2) were very specific in detecting those cytokines 
in the stimulated cultures from human lymphocytes and 
were not able to recognize canine IFN-γ. A similar profile 
was found for the anti-human IL-2 mAb tested. Finally, 
low levels of IL-1β and IL-10 was observed in human 
lymphocytes and was absent in canine cells (Fig. 2).
The range of intracytoplasmic cytokine labeling 
in peripheral blood lymphocytes from healthy dogs 
detected by the selected cross-reactivity reagents are 
shown in Fig. 6.
Isotype matching controls and Fc‑γ‑R blocking
To address whether the cross-reactivity of the anti-
human cytokine mAbs with canine cytokines could be a 
non-specific reaction via Fcγ-R binding, an experiment 
including internal isotypic controls as well as blocking 
pre-incubation in the presence of 2 % of mAbs host sera 
reagent was performed (Fig.  3). This strategy was used 
Fig. 3 Internal controls to validate the cross‑reactivity of anti‑human cytokine mAbs with canine cytokines following short‑term whole blood 
cultures in vitro. Unspecific binding were monitored by using isotypic matching reagents (top panels). Blocking strategy with host serum were also 
applied (bottom panels). Controls of reference cross‑reactive mAbs (anti‑bovina IFN‑γ and IL‑4) were also included. Dot plot distribution graphs of 
empty channel (FL4 fluorescence) versus PE‑emission channel (FL2) were used to quantify the percentage of cytokine+ lymphocytes in unstimu‑
lated controls (left panels) and PMA + LPS stimulated cultures (right panels). Only Q1 and Q4 quadrants are represented. Gray background highlights 
the reactivity above 0.5 % in the quadrant Q1
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to provide a major source of unlabeled IgG for species-
specific Fcγ-R blocking by competitive binding. Moreo-
ver, a parallel analysis of intracytoplasmic staining with 
the reference cross-reactive reagents was also performed. 
Consistent with our previous observations (Fig.  2), no 
differences could be observed in the “presence” of “Fc-
γR blocking for the anti-human IL1-α, IL-4, TNF-α (#2) 
mAbs and anti-bovine IL-4 and IFN-γ control mAbs 
(Fig. 3).
Applicability of anti‑human cytokine mAbs to characterize 
the immunological status of diseased dogs
After the cross-reactivity panel was established, we per-
formed an additional experiment to evaluate the appli-
cability of the selected anti-human cytokine mAbs to 
characterize the immunological status of diseased dogs 
including peritonitis (Dog #1) and dermatitis (Dog #2). 
Data analysis demonstrated that both dogs exhibited a 
different cytokine pattern depending on the pathology 
(Fig.  4). Dog #1 exhibited an increase in the intracyto-
plasmic levels of IL-6, IL-12, IL-17A and TGF-β, whereas 
dog #2 showed increased expression of IL-1α, IL-12, 17A 
and TGF-β by lymphocytes.
Two commercially available anti-bovine cytokine mAbs 
(IL-4 and IFN-γ) are currently used to mark canine leu-
kocytes producing theses cytokines. Theses mAbs were 
used to compare the reactivity observed by anti-human 
cytokine-cross-reacting mAbs tested. As expected, a 
positive strong correlation between the percentage of 
positive cells marked with anti-human and anti-bovine 
IL-4 mAbs was observed (r = 0.770 and P < 0.001), while 
no correlation was observed between the anti-human 
IFN-γ mAb (not reactive) and anti-bovine IFN-γ mAb 
(r = 0.059 and P = 0.444) (Fig. 5).
In order to confirm the mAbs cross-reactivity in  situ, 
canine T-lymphocytes were stained with anti-dog CD3-
FITC plus anti-human cytokines-PE [TGF-β, IL-8 (#2) 
and IL-4]. The cells were evaluated employing Zeiss laser 
Fig. 4 Applicability of cross‑reacted anti‑human cytokine mAbs (IL‑1‑α, IL‑6, IL‑12, IL‑17A and TGF‑β) to quantify cytokine+ lymphocytes from 
unhealthy dogs, including peritonitis (Dog #1) and dermatitis (Dog #2). Dot plot distribution graphs of empty channel (FL4 fluorescence) versus PE‑
emission channel (FL2) were used to quantify the percentage of cytokine+ lymphocytes in unstimulated controls (left panels) and PMA + LPS stimu‑
lated cultures (right panels). Only Q1 and Q4 quadrants are represented. Gray background highlights the reactivity above 0.5 % in the quadrant Q1
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Fig. 5 Correlation analysis of cytokine+ lymphocytes detected by commercially available anti‑human cytokine mAbs (IL‑4 and IFN‑γ) and the refer‑
ence cross‑reactivity reagent (anti‑bonive IL‑4 and IFN‑γ). a Dot plot distribution graphs of empty channel (FL4 fluorescence) versus PE‑emission 
channel (FL2) were used to quantify the percentage of cytokine+ lymphocytes (IFN‑γ #1—upper panel and IL‑4—bottom panel). Only Q1 and Q4 
quadrants are represented. Gray background highlights the reactivity above 0.5 % in the quadrant Q1. b Spearman correlation plots of the frequency 
of cytokine+ lymphocytes stained with each mAbs (anti‑human versus reference anti‑bovine mAbs)
Fig. 6 Range of intracytoplasmic cytokine labeling in peripheral blood lymphocytes from healthy dogs detected by the selected cross‑reactivity 
reagents. The frequency of cytokine+ lymphocytes was assessed in a total of 8‑45 healthy dogs. The results are expressed as scattering of individual 
values for IL‑1α, IL‑4, IL‑5, IL‑6, IL‑8 (#1), IL‑8 (#2), IL‑12, IL‑17A, TNF‑α (#1), TNF‑α (#2) and TGF‑β
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scanning inverted microscope. Cellular co-localization of 
CD3 and TGF-β, IL-8 (#2) or IL-4 was detected (Fig. 7). 
These results confirmed the cross-reactivity data shown 
by the flow cytometric analysis.
Discussion
In this work we have screened 17 monoclonal antibod-
ies against human cytokines and their cross-reactivity 
against canine lymphocytes. Cross-reactivity studies 
using well-defined mAbs are an important and rapid tool 
to obtain reagents that will be suitable for immunological 
studies in veterinary medicine.
The rationale of performing such studies lies in the fact 
that it is much more economical to identify useful immu-
nological cross-reactivity of existing well-defined mono-
clonal antibodies than to produce new reagents, since the 
development and production of new mAbs is time-con-
suming and expensive. In some species a limited number 
Fig. 7 Confocal analysis of intracytoplamic stained cytokines. a Stimulated cells (PMA + LPS) were stained with FITC‑labeled rat anti‑canine CD3 
and b PE‑labeled anti‑human TGF‑β, IL‑8 (#2) and IL‑4. Images from both staining were merged (c)
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of marker antibodies are available. Therefore, the search 
for monoclonal antibodies generated against antigens 
derived from other species for their cross-reactivity and 
systematic studies have been performed [18, 20, 25–28]. 
Some cross-reacting antibodies have been employed to 
study canine hematopoietic cells [29, 30], canine lympho-
mas [31], canine lymphocyte subsets [32] or the canine 
leukocyte adhesion deficiency syndrome (CLAD) [33].
The advent of intracellular cytokine assessment by flow 
cytometry, through staining of permeabilized cells with 
fluorochrome conjugated anti-cytokine antibodies, per-
mits large numbers of cells of known phenotypes to be 
examined. Flow cytometry allows both quantitative and 
statistical analysis of variable cell molecules expressed 
on the cellular membrane or cytoplasm in each individ-
ual cell within a short time period. Intracellular cytokine 
staining is quite important in defining functional subsets 
in mixed T cell populations. In this work, we employed 
a standard protocol for in vitro short-term whole blood 
culture using flow cytometry-based immunofluorescence 
assay to test the cross-reactivity of seventeen commer-
cially available PE-labeled anti-human cytokine mAbs. 
Basal cytokine and PMA +  IONO +  LPS-induced plus 
cytokine profiles were evaluated and the cross-reactiv-
ity with canine intracytoplasmatic cytokines assessed 
by comparative analysis with the standard reactivity in 
human lymphocytes. The results of this study showed 
that short culture times (4  h) for canine whole-blood 
samples are satisfactory for the cytokine evaluation. Data 
analysis demonstrated that eleven out of seventeen anti-
human cytokine mAbs (IL-1α, IL-4, IL-5, IL-6, IL-8 (#1 
and #2), IL-12, IL-17A, TNF-α (#1 and #2), TGF-β) cross-
reacted with canine cytokines. Otherwise, no cross-
reactivity with the canine cytokines was observed by six 
anti-human cytokine mAbs [IL-1β, IL-2, IL-10, IL-13, 
IFN-γ (#1 and #2)].
Comparison of the available amino acid sequences of 
the human cytokines for which the mAbs were generated 
and canine cytokines showed homologies from 49 % up 
to 96 % (Table 2) (http://www.ncbi.nlm.nih.gov/BLAST/) 
consistent with an occurrence of cross-reactivity. Main-
tenance of epitopes on molecules may reflect functional 
importance of the region of the molecule recognized, and 
an evolutionary pressure to conserve those regions [34]. 
Some results found in this study and by others [11, 22, 
23] do not completely support the idea that high homol-
ogy lead to reactivity, probably because the epitopes 
recognized by mAbs are not in regions that have been 
conserved evolutionarily. Comparative studies of the 
reactivity with cells from several species have shown that 
each antibody recognizes a different epitope [12]. Dern-
falk et al. [11] tested five commercially available antibod-
ies against human TNF-α towards ovine and bovine, but 
found only two antibodies with satisfactory reactivity 
with the ovine, but none with the bovine TNF-α. Thus, 
it is often necessary that several antibodies against the 
same antigen should be tested, which could suggest that 
a cross-reacting mAb could be found if other different 
clones were screened.
Anti-human IL-8, IL-12, IL-17A, and TNF-α (#1, #2) 
mAbs strongly reacted against intracellular cytokines in 
the canine lymphocytes. These results are supported by a 
high degree of similarity found among human and canine 
cytokines evaluated (Table 2). They showed high homol-
ogy among species (77, 84, 81, 85 and 91 %, respectively). 
In spite of the lower homology between human and 
canine IL-6 (59 %), the monoclonal antibody anti- human 
IL-6 showed cross-reactivity with the canine cytokine. 
On the other hand, IL-1β, IL-2, IL-10 and IL-13 pre-
sented high homology between canine and human (78, 
74, 78, 72  %, respectively), but no cross-reactivity was 
observed by the anti-human mAb clones tested against 
those cytokines.
IL-8 is a very important pro-inflammatory cytokine, 
the possibility to study its production by canine leuko-
cytes through flow cytometry employing mAbs could 
help to understand the immunopathology in different 
diseases (infectious or not). In addition, cross-reac-
tivity of anti-human IL-17A mAb opens a new possi-
bility for investigating the relevance of TH17 cells in 
the immune response of dogs. Although presenting 
homology of 78 %, the human anti-IL-10 mAb did not 
Table 2 Homology of  the amino acid sequences 
between  the canine and  human or bovine cytokines tar-
geted by the evaluated anti-human or anti-bovine mAbs
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react with the canine cytokine. The finding of a mAb 
reactive against canine IL-10 would be very useful, 
since this is an important cytokine involved in immu-
noregulation. It may induce down-regulation of Th1 
cytokines expression, MHC class II antigens, and act-
ing as co-stimulatory molecule on macrophages. It 
also enhances B cell survival, proliferation, and anti-
body production. IL-10 can block NF-κB activity, and 
is involved in the regulation of the JAK-STAT signaling 
pathway [35, 36].
Results for both human anti-TNF-α mAb (Clone B-C7 
or mab11) showed a good cross-reactivity with canine 
TNF-α, similar to the pattern found for human cells. 
These results are not surprising because this cytokine has 
great homology between human and canine. This find-
ing is promissory, since that TNF-α is a important innate 
pro-inflammatory cytokine involved in protection against 
intracellular pathogens, and sometimes the identification 
of cross-reactivity among evolutionarily related species 
have been difficult [11, 22].
To validate the cross-reactivity findings, an addi-
tional experiment was performed to evaluate the appli-
cability of the selected anti-human cytokine mAbs. 
It was performed to characterize the immunological 
status of dogs under pathological conditions includ-
ing peritonitis (Dog #1) and dermatitis (Dog #2). We 
observed that both dogs exhibited a different cytokine 
patterns depending on the pathology. The dog with 
peritonitis exhibited increased intracytoplasmic lev-
els of IL-6, IL-12, IL-17A and TGF-β, whereas the 
dog with dermatitis presented increased expressions 
of IL-1α, IL-12 and TGF-β in lymphocytes. Increased 
expression for most cytokines in cells from dogs with 
peritonitis (Dog #1) and dermatitis (Dog #2) as com-
pared with healthy animals, reinforced the impor-
tance and applicability of the cross-reactive mAbs 
to increase the portfolio of mAbs against canine 
cytokines available.
The results presented here demonstrate the potential of 
cross-reactive monoclonal antibody against distinct spe-
cies by immunofluorescence assays to monitor the fre-
quency of cells producing cytokines. Additonately, this 
approach may further permit the evaluation of immune 
response in various canine disorders with the potential 
for monitoring therapy and vaccine protocols.
Conclusion
This study described a wide range of anti-human cytokine 
mAbs (IL-1α, IL-4, IL-5, IL-6, IL-8(#1, #2), IL-12, IL-17A, 
TNF-α (#1, #2), TGF-β) that cross-reacted with canine 
cytokines and could be useful canine immunological 
biomarkers for pathological conditions employing flow 
cytometry and fluorescence microscopy.
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